Bellerophon Therapeutics, Inc. 4
4 · Bellerophon Therapeutics, Inc. · Filed Dec 1, 2016
Insider Transaction Report
Form 4
Tenenbaum Fabian
Chief Executive Officer
Transactions
- Purchase
Common Stock
2016-11-29+142,857→ 142,857 total - Purchase
Common Stock Warrants (right to buy)
2016-11-29+142,857→ 142,857 totalExercise: $0.80From: 2016-11-29Exp: 2021-11-29→ Common Stock (142,857 underlying)
Footnotes (1)
- [F1]The reported securities are included within 142,857 Class A Units purchased by the reporting person for $0.70 per Class A Unit. Each Class A Unit consists of one share of common stock and one warrant to purchase one share of common stock.